Biotech Company Finds Beneficial Results From Anti-Aging Gene Therapy

By B.J. Murphy

Last year biotech company BioViva made headlines after revealing that its CEO Elizabeth Parrish decided to be “patient zero” for a new anti-aging gene therapy trial. To make the entire experiment all the more bold, they conducted it outside of the U.S. to avoid FDA regulations.

While Parrish and her company are still anxiously waiting for full results, initial results are now starting to come in and they’re looking pretty damn good!

If you’d like to remain updated on BioViva’s activities and overall results from their anti-aging gene therapy trial, be sure to head on over to their main website and bookmark their blog.

Photo Credit: BioViva

As shown in the MRI image provided above, in the course of 10 months after starting the trial, Parrish’s thighs are beginning to show growth in overall mass, with a subsequent reduction in intramuscular triglyceride content (muscle fat). Not only that, there are also signs of a significant reduction in fasting blood glucose, thereby “suggesting increased insulin sensitivity.”

These are all signs of a clear increase in metabolic health. When you couple in signs of lowered blood triglycerides, it would appear that Parrish’s cardiovascular health is also showing steady improvements with no detrimental effects thus far.

Whether or not these are the results of the biotech company’s dual gene therapies – consisting of a myostatin inhibitor and telomerase inducer – is yet to be known, but if they are, BioViva is in the midst of a huge breakthrough!

FUTURE IMPLICATIONS

If BioViva is successful with their anti-aging gene therapy research, we could be on the brink of a major medical revolution – one which consists of finally putting an end to aging for good. Of course, like most of anything in regards to science, we first need results with plenty of evidence to verify them. If it can survive scientific scrutiny, all of us could potentially benefit from such a massive disruption in the health industry. And if it doesn’t, then it’s right back to the drawing board. Either way, it doesn’t appear that this biotech company is going to stop until they finally discover the “fountain of youth.” For which, we wish them the best of luck!

December 1, 2016 By B.J. Murphy

About the author

B.J. Murphy is the Editor and Social Media Manager of Serious Wonder. He is a futurist, philosopher, activist, author and poet. B.J. is an Affiliate Scholar for the Institute for Ethics and Emerging Technologies (IEET) and an Ambassador for the robotics company Humai.

Jason Reagan

But I like statues!
Tim Suetens

Let’s hold off on building her statues, and indeed see if the changes are truly due to the therapy. And if they are, the changes are still small enough they could be due to a deviation caused by something else – which isn’t exactly a compliment for the treatment, is it?
Jason Reagan

When humanity looks back at the pioneers of longevity, Elizabeth Parrish will surely deserve a statue in every park.

One thing I do wonder: have they controlled for other possible causes? One might think Parrish would, consciously or unconsciously pay closer attention to diet and exercise during this experiment which could surely contribute to her improvements. My guess is they are indeed controlling for her behavioral/lifestyle choices.